Prospero BioSciences
Sun Prairie
About Prospero BioSciences
Prospero Biosciences transforms the way scientists and clinicians quantitatively analyze ultra-high protein masses. With our patented ultra-high mass detection system, our researchers are able to extend the dynamic range limits to an unprecedented resolution. Our integrated system can currently be retrofitted to MALDI-TOF mass spectrometric instruments. In the near future, retrofits to ESI and Q-TOF instruments will be available. Our ultra-high mass detection system assist scientists and clinicians make extraordinary advancements for all applications in virus detection, pharmaceutical drugs, toxicology, proteomics, genomics, metabolomics, and diagnostics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $20.1K
- Funding stage: Seed
- Last round: Seed (Nov 2013)
- Website: prosperobiosciences.com
Industries & Categories
Biotechnology, Health Diagnostics, Nanotechnology
Social Profiles
Canonical: https://fsome.com/organization/prospero-biosciences-3703282 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.